Results 251 to 260 of about 33,889 (327)

A minor high‐grade component in non‐invasive papillary urothelial carcinoma is not associated with a more indolent behaviour

open access: yesHistopathology, EarlyView.
Non‐invasive papillary urothelial carcinomas with minor high‐grade component are not associated with a more indolent behavior and should likely be regarded as high‐grade carcinomas. Aims The latest WHO edition proposed using a cut‐off of ≥5% high‐grade component (%HGc) as a criterion to label non‐invasive papillary urothelial carcinomas as high‐grade ...
Mina S. Farag   +5 more
wiley   +1 more source

Outcomes of Nivolumab‐Plus‐Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J‐ENCORE Study

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Objectives J‐ENCORE is a multicenter prospective observational study in Japan involving advanced or metastatic renal cell carcinoma patients receiving nivolumab‐plus‐ipilimumab (NIVO+IPI) as first‐line treatment. The minimum 1‐year observation revealed the efficacy and safety of NIVO+IPI comparable to those in CheckMate 214, and evaluated ...
Tomokazu Sazuka   +14 more
wiley   +1 more source

Correction: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population. [PDF]

open access: yesFront Oncol
Wang Z   +10 more
europepmc   +1 more source

Prediction of Postoperative Intravesical Recurrence Using Urine DNA Monitoring in Nonmuscular‐Invasive Urothelial Bladder Cancer

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Objectives Considering the high frequency of intravesical recurrence in bladder urothelial carcinoma (UBC), accurate non‐invasive biomarkers for recurrence prediction are needed for better management after transurethral surgery. This pilot study examined the usefulness of urine DNA for detecting and predicting intravesical recurrence in UBC ...
Masashi Shiozaki   +6 more
wiley   +1 more source

Magnetic Resonance Imaging–Transrectal Ultrasound Fusion‐Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Objectives As the diagnostic efficacy and safety of magnetic resonance imaging (MRI)–transrectal ultrasound (TRUS) fusion‐targeted transrectal biopsy for prostate cancer (PCa) detection have already been demonstrated when compared with those of conventional systematic biopsy, we aimed to further evaluate them.
Yusuke Fukiage   +15 more
wiley   +1 more source

Associated urological malformations and development of chronic kidney disease in pediatric patients with urinary tract infection at San Vicente de Paúl Hospital (Medellín, Colombia) between 1960 and 2010 [PDF]

open access: green, 2013
Juan José Vanegas Ruiz   +8 more
openalex  

Home - About - Disclaimer - Privacy